A discovery about red blood cells could have implications for sickle cell disease (SCD) and other blood disorders marked…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A global, late-stage clinical trial testing etavopivat in people with sickle cell disease (SCD) has hit its main…
People with sickle cell disease (SCD) who live in sub-Saharan Africa are less likely than those in other countries…
Clinician bias toward people with sickle cell disease (SCD) may be tied to stigma around opioid use, rather than…
Through a project aimed at building empathy and understanding among clinicians about sickle cell disease (SCD)-related pain episodes, a…
A bipartisan team of U.S. senators has introduced legislation to renew funding for a national initiative that connects people with…
Newborns with sickle cell trait (SCT), meaning they carry a mutation in one copy of the HBBÂ gene but do not…
Most women and girls with sickle cell disease (SCD) experience disease-related pain during menstrual periods, but many are unaware…
A small clinical trial testing Agios Pharmaceuticals’ oral therapy candidate tebapivat against a placebo for easing symptoms in people…
Differences in the stiffness of red blood cells may help to explain variations in the severity of sickle cell…